ICU Medical traded at $161.62 this Tuesday September 8th, decreasing $5.96 or 3.56 percent since the previous trading session. Looking back, over the last four weeks, ICU Medical lost 11.40 percent. Over the last 12 months, its price rose by 23.78 percent. Looking ahead, we forecast ICU Medical to be priced at 163.55 by the end of this quarter and at 153.32 in one year, according to Trading Economics global macro models projections and analysts expectations.
ICU Medical, Inc. (ICU) develops, manufactures and sells medical products used in infusion therapy, and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical safety. ICU's primary critical care products include Cogent, CardioFlo, TDQ and OptiQ, TriOx, Transpac and SafeSet. Cogent, which is a two-in-one hemodynamic monitoring system. CardioFlo, which is a hemodynamic monitoring system. TDQ and OptiQ, which are cardiac output monitoring catheters. TriOxTM, which is venous oximetry catheters. Transpac are blood pressure transducers. SafeSet, which is a closed blood sampling and conservation system.